FDA releases guidance on clinical trials backing PMA applications

08/17/2011 | MassDevice.com (Boston)

The FDA has issued another guidance outlining the basic features of clinical trials designed to support medical devices seeking premarket approval, which will be up for comment over the next three months. The guidance, which may also be applicable to 510(k) submissions, "will help manufacturers and researchers better understand the FDA's basic expectations for clinical trials," said Dr. Jeffrey Shuren, director of the FDA's device center.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI